Crossingbridge Advisors’s Drugs Made In America Acquisition Corp. Ordinary Shares DMAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-850,000
Closed -$1.3M 114
2025
Q1
$1.3M Buy
+850,000
New +$1.3M 0.68% 31